Uncategorized

In Rapid Rise of AI, Employers Turn to Business School Graduates for Human Skills

GMAC’s annual survey of corporate recruiters indicates high confidence, predicts strong hiring RESTON, Va., July 01, 2024 (GLOBE NEWSWIRE) —  Despite concerns about inflation and recession risk, employer confidence in graduate management education (GME) and its ability to prepare business school graduates to be successful in their organizations has reached new heights since the pandemic, […]

Read more
Uncategorized

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment […]

Read more
Uncategorized

Aleph Group Acquires Entravision’s Digital Advertising Business

Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primarily emerging markets, today announced the completion of its acquisition of Entravision Global Partners (“EGP”), the digital commercial partnership business unit of Entravision Communications Corporation. This  […]

Read more
Uncategorized

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company submitted the fourth and final module […]

Read more